FDA Clearance Tracker · P840024-S094
Nucleus Cochlear Implant Systems
Last checked: Nov 20, 2026Latest source record: Oct 31, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Oct 31, 2022
Approved
Time to decision
188 days
Received Apr 26, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P840024-S094
- Device name
- Nucleus Cochlear Implant Systems
- Applicant
- Cochlear Americas
- Applicant location
- Lone Tree, CO
- Received
- Apr 26, 2022
- Decided
- Oct 31, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P840024
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
for a new sound processor (Nucleus 8 Sound Processor) and two supporting software devices (Custom Sound Pro and Nucleus Smart App)
Source documents
Other decisions for Cochlear Americas
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260902 · Decided Jul 10, 2026 · 114 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.